The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oligonucleotide API Market Research Report 2025
Synopsis
The global Oligonucleotide API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Oligonucleotide API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Oligonucleotide API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Oligonucleotide API include Jazz Pharmaceuticals, Sarepta Therapeutics, Biogen, Dynavax Technologies, Akcea Therapeutics, Alnylam Pharmaceuticals, Nitto Denko (Avecia), Ajinomoto (GeneDesign) and RiboBio, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oligonucleotide API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oligonucleotide API.
Report Scope
The Oligonucleotide API market size, estimations, and forecasts are provided in terms of output/shipments (Ton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oligonucleotide API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oligonucleotide API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Jazz Pharmaceuticals
Sarepta Therapeutics
Biogen
Dynavax Technologies
Akcea Therapeutics
Alnylam Pharmaceuticals
Nitto Denko (Avecia)
Ajinomoto (GeneDesign)
RiboBio
Segment by Type
Antisense Oligonucleotides API
Small Interfering RNA (siRNA) API
MiRNA API
CpG Oligonucleotides API
Others
Segment by Application
Contract Manufacturing Organizations (CMOs)
Pharmaceutical Companies
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oligonucleotide API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Oligonucleotide API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Oligonucleotide API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
The global Oligonucleotide API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Oligonucleotide API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Oligonucleotide API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Oligonucleotide API include Jazz Pharmaceuticals, Sarepta Therapeutics, Biogen, Dynavax Technologies, Akcea Therapeutics, Alnylam Pharmaceuticals, Nitto Denko (Avecia), Ajinomoto (GeneDesign) and RiboBio, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oligonucleotide API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oligonucleotide API.
Report Scope
The Oligonucleotide API market size, estimations, and forecasts are provided in terms of output/shipments (Ton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oligonucleotide API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oligonucleotide API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Jazz Pharmaceuticals
Sarepta Therapeutics
Biogen
Dynavax Technologies
Akcea Therapeutics
Alnylam Pharmaceuticals
Nitto Denko (Avecia)
Ajinomoto (GeneDesign)
RiboBio
Segment by Type
Antisense Oligonucleotides API
Small Interfering RNA (siRNA) API
MiRNA API
CpG Oligonucleotides API
Others
Segment by Application
Contract Manufacturing Organizations (CMOs)
Pharmaceutical Companies
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oligonucleotide API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Oligonucleotide API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Oligonucleotide API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Oligonucleotide API Market Overview
1.1 Product Definition
1.2 Oligonucleotide API Segment by Type
1.2.1 Global Oligonucleotide API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Antisense Oligonucleotides API
1.2.3 Small Interfering RNA (siRNA) API
1.2.4 MiRNA API
1.2.5 CpG Oligonucleotides API
1.2.6 Others
1.3 Oligonucleotide API Segment by Application
1.3.1 Global Oligonucleotide API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Contract Manufacturing Organizations (CMOs)
1.3.3 Pharmaceutical Companies
1.4 Global Market Growth Prospects
1.4.1 Global Oligonucleotide API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Oligonucleotide API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Oligonucleotide API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Oligonucleotide API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Oligonucleotide API Production Market Share by Manufacturers (2019-2024)
2.2 Global Oligonucleotide API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Oligonucleotide API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Oligonucleotide API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Oligonucleotide API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Oligonucleotide API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Oligonucleotide API, Product Offered and Application
2.8 Global Key Manufacturers of Oligonucleotide API, Date of Enter into This Industry
2.9 Oligonucleotide API Market Competitive Situation and Trends
2.9.1 Oligonucleotide API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Oligonucleotide API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Oligonucleotide API Production by Region
3.1 Global Oligonucleotide API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Oligonucleotide API Production Value by Region (2019-2030)
3.2.1 Global Oligonucleotide API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Oligonucleotide API by Region (2025-2030)
3.3 Global Oligonucleotide API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Oligonucleotide API Production by Region (2019-2030)
3.4.1 Global Oligonucleotide API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Oligonucleotide API by Region (2025-2030)
3.5 Global Oligonucleotide API Market Price Analysis by Region (2019-2024)
3.6 Global Oligonucleotide API Production and Value, Year-over-Year Growth
3.6.1 North America Oligonucleotide API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Oligonucleotide API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Oligonucleotide API Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Oligonucleotide API Production Value Estimates and Forecasts (2019-2030)
4 Oligonucleotide API Consumption by Region
4.1 Global Oligonucleotide API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Oligonucleotide API Consumption by Region (2019-2030)
4.2.1 Global Oligonucleotide API Consumption by Region (2019-2024)
4.2.2 Global Oligonucleotide API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Oligonucleotide API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Oligonucleotide API Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Oligonucleotide API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Oligonucleotide API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Oligonucleotide API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Oligonucleotide API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Oligonucleotide API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Oligonucleotide API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Oligonucleotide API Production by Type (2019-2030)
5.1.1 Global Oligonucleotide API Production by Type (2019-2024)
5.1.2 Global Oligonucleotide API Production by Type (2025-2030)
5.1.3 Global Oligonucleotide API Production Market Share by Type (2019-2030)
5.2 Global Oligonucleotide API Production Value by Type (2019-2030)
5.2.1 Global Oligonucleotide API Production Value by Type (2019-2024)
5.2.2 Global Oligonucleotide API Production Value by Type (2025-2030)
5.2.3 Global Oligonucleotide API Production Value Market Share by Type (2019-2030)
5.3 Global Oligonucleotide API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Oligonucleotide API Production by Application (2019-2030)
6.1.1 Global Oligonucleotide API Production by Application (2019-2024)
6.1.2 Global Oligonucleotide API Production by Application (2025-2030)
6.1.3 Global Oligonucleotide API Production Market Share by Application (2019-2030)
6.2 Global Oligonucleotide API Production Value by Application (2019-2030)
6.2.1 Global Oligonucleotide API Production Value by Application (2019-2024)
6.2.2 Global Oligonucleotide API Production Value by Application (2025-2030)
6.2.3 Global Oligonucleotide API Production Value Market Share by Application (2019-2030)
6.3 Global Oligonucleotide API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Jazz Pharmaceuticals
7.1.1 Jazz Pharmaceuticals Oligonucleotide API Corporation Information
7.1.2 Jazz Pharmaceuticals Oligonucleotide API Product Portfolio
7.1.3 Jazz Pharmaceuticals Oligonucleotide API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Jazz Pharmaceuticals Main Business and Markets Served
7.1.5 Jazz Pharmaceuticals Recent Developments/Updates
7.2 Sarepta Therapeutics
7.2.1 Sarepta Therapeutics Oligonucleotide API Corporation Information
7.2.2 Sarepta Therapeutics Oligonucleotide API Product Portfolio
7.2.3 Sarepta Therapeutics Oligonucleotide API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Sarepta Therapeutics Main Business and Markets Served
7.2.5 Sarepta Therapeutics Recent Developments/Updates
7.3 Biogen
7.3.1 Biogen Oligonucleotide API Corporation Information
7.3.2 Biogen Oligonucleotide API Product Portfolio
7.3.3 Biogen Oligonucleotide API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Biogen Main Business and Markets Served
7.3.5 Biogen Recent Developments/Updates
7.4 Dynavax Technologies
7.4.1 Dynavax Technologies Oligonucleotide API Corporation Information
7.4.2 Dynavax Technologies Oligonucleotide API Product Portfolio
7.4.3 Dynavax Technologies Oligonucleotide API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Dynavax Technologies Main Business and Markets Served
7.4.5 Dynavax Technologies Recent Developments/Updates
7.5 Akcea Therapeutics
7.5.1 Akcea Therapeutics Oligonucleotide API Corporation Information
7.5.2 Akcea Therapeutics Oligonucleotide API Product Portfolio
7.5.3 Akcea Therapeutics Oligonucleotide API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Akcea Therapeutics Main Business and Markets Served
7.5.5 Akcea Therapeutics Recent Developments/Updates
7.6 Alnylam Pharmaceuticals
7.6.1 Alnylam Pharmaceuticals Oligonucleotide API Corporation Information
7.6.2 Alnylam Pharmaceuticals Oligonucleotide API Product Portfolio
7.6.3 Alnylam Pharmaceuticals Oligonucleotide API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Alnylam Pharmaceuticals Main Business and Markets Served
7.6.5 Alnylam Pharmaceuticals Recent Developments/Updates
7.7 Nitto Denko (Avecia)
7.7.1 Nitto Denko (Avecia) Oligonucleotide API Corporation Information
7.7.2 Nitto Denko (Avecia) Oligonucleotide API Product Portfolio
7.7.3 Nitto Denko (Avecia) Oligonucleotide API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Nitto Denko (Avecia) Main Business and Markets Served
7.7.5 Nitto Denko (Avecia) Recent Developments/Updates
7.8 Ajinomoto (GeneDesign)
7.8.1 Ajinomoto (GeneDesign) Oligonucleotide API Corporation Information
7.8.2 Ajinomoto (GeneDesign) Oligonucleotide API Product Portfolio
7.8.3 Ajinomoto (GeneDesign) Oligonucleotide API Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Ajinomoto (GeneDesign) Main Business and Markets Served
7.7.5 Ajinomoto (GeneDesign) Recent Developments/Updates
7.9 RiboBio
7.9.1 RiboBio Oligonucleotide API Corporation Information
7.9.2 RiboBio Oligonucleotide API Product Portfolio
7.9.3 RiboBio Oligonucleotide API Production, Value, Price and Gross Margin (2019-2024)
7.9.4 RiboBio Main Business and Markets Served
7.9.5 RiboBio Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Oligonucleotide API Industry Chain Analysis
8.2 Oligonucleotide API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Oligonucleotide API Production Mode & Process
8.4 Oligonucleotide API Sales and Marketing
8.4.1 Oligonucleotide API Sales Channels
8.4.2 Oligonucleotide API Distributors
8.5 Oligonucleotide API Customers
9 Oligonucleotide API Market Dynamics
9.1 Oligonucleotide API Industry Trends
9.2 Oligonucleotide API Market Drivers
9.3 Oligonucleotide API Market Challenges
9.4 Oligonucleotide API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of TablesList of Tables
Table 1. Global Oligonucleotide API Market Value by Type, (US$ Million) & (2023 VS 2030)
Table 2. Global Oligonucleotide API Market Value by Application, (US$ Million) & (2023 VS 2030)
Table 3. Global Oligonucleotide API Production Capacity (Ton) by Manufacturers in 2023
Table 4. Global Oligonucleotide API Production by Manufacturers (2019-2024) & (Ton)
Table 5. Global Oligonucleotide API Production Market Share by Manufacturers (2019-2024)
Table 6. Global Oligonucleotide API Production Value by Manufacturers (2019-2024) & (US$ Million)
Table 7. Global Oligonucleotide API Production Value Share by Manufacturers (2019-2024)
Table 8. Global Oligonucleotide API Industry Ranking 2022 VS 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oligonucleotide API as of 2023)
Table 10. Global Market Oligonucleotide API Average Price by Manufacturers (US$/Ton) & (2019-2024)
Table 11. Manufacturers Oligonucleotide API Production Sites and Area Served
Table 12. Manufacturers Oligonucleotide API Product Types
Table 13. Global Oligonucleotide API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global Oligonucleotide API Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 16. Global Oligonucleotide API Production Value (US$ Million) by Region (2019-2024)
Table 17. Global Oligonucleotide API Production Value Market Share by Region (2019-2024)
Table 18. Global Oligonucleotide API Production Value (US$ Million) Forecast by Region (2025-2030)
Table 19. Global Oligonucleotide API Production Value Market Share Forecast by Region (2025-2030)
Table 20. Global Oligonucleotide API Production Comparison by Region: 2019 VS 2023 VS 2030 (Ton)
Table 21. Global Oligonucleotide API Production (Ton) by Region (2019-2024)
Table 22. Global Oligonucleotide API Production Market Share by Region (2019-2024)
Table 23. Global Oligonucleotide API Production (Ton) Forecast by Region (2025-2030)
Table 24. Global Oligonucleotide API Production Market Share Forecast by Region (2025-2030)
Table 25. Global Oligonucleotide API Market Average Price (US$/Ton) by Region (2019-2024)
Table 26. Global Oligonucleotide API Market Average Price (US$/Ton) by Region (2025-2030)
Table 27. Global Oligonucleotide API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Ton)
Table 28. Global Oligonucleotide API Consumption by Region (2019-2024) & (Ton)
Table 29. Global Oligonucleotide API Consumption Market Share by Region (2019-2024)
Table 30. Global Oligonucleotide API Forecasted Consumption by Region (2025-2030) & (Ton)
Table 31. Global Oligonucleotide API Forecasted Consumption Market Share by Region (2019-2024)
Table 32. North America Oligonucleotide API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Ton)
Table 33. North America Oligonucleotide API Consumption by Country (2019-2024) & (Ton)
Table 34. North America Oligonucleotide API Consumption by Country (2025-2030) & (Ton)
Table 35. Europe Oligonucleotide API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Ton)
Table 36. Europe Oligonucleotide API Consumption by Country (2019-2024) & (Ton)
Table 37. Europe Oligonucleotide API Consumption by Country (2025-2030) & (Ton)
Table 38. Asia Pacific Oligonucleotide API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Ton)
Table 39. Asia Pacific Oligonucleotide API Consumption by Region (2019-2024) & (Ton)
Table 40. Asia Pacific Oligonucleotide API Consumption by Region (2025-2030) & (Ton)
Table 41. Latin America, Middle East & Africa Oligonucleotide API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Ton)
Table 42. Latin America, Middle East & Africa Oligonucleotide API Consumption by Country (2019-2024) & (Ton)
Table 43. Latin America, Middle East & Africa Oligonucleotide API Consumption by Country (2025-2030) & (Ton)
Table 44. Global Oligonucleotide API Production (Ton) by Type (2019-2024)
Table 45. Global Oligonucleotide API Production (Ton) by Type (2025-2030)
Table 46. Global Oligonucleotide API Production Market Share by Type (2019-2024)
Table 47. Global Oligonucleotide API Production Market Share by Type (2025-2030)
Table 48. Global Oligonucleotide API Production Value (US$ Million) by Type (2019-2024)
Table 49. Global Oligonucleotide API Production Value (US$ Million) by Type (2025-2030)
Table 50. Global Oligonucleotide API Production Value Share by Type (2019-2024)
Table 51. Global Oligonucleotide API Production Value Share by Type (2025-2030)
Table 52. Global Oligonucleotide API Price (US$/Ton) by Type (2019-2024)
Table 53. Global Oligonucleotide API Price (US$/Ton) by Type (2025-2030)
Table 54. Global Oligonucleotide API Production (Ton) by Application (2019-2024)
Table 55. Global Oligonucleotide API Production (Ton) by Application (2025-2030)
Table 56. Global Oligonucleotide API Production Market Share by Application (2019-2024)
Table 57. Global Oligonucleotide API Production Market Share by Application (2025-2030)
Table 58. Global Oligonucleotide API Production Value (US$ Million) by Application (2019-2024)
Table 59. Global Oligonucleotide API Production Value (US$ Million) by Application (2025-2030)
Table 60. Global Oligonucleotide API Production Value Share by Application (2019-2024)
Table 61. Global Oligonucleotide API Production Value Share by Application (2025-2030)
Table 62. Global Oligonucleotide API Price (US$/Ton) by Application (2019-2024)
Table 63. Global Oligonucleotide API Price (US$/Ton) by Application (2025-2030)
Table 64. Jazz Pharmaceuticals Oligonucleotide API Corporation Information
Table 65. Jazz Pharmaceuticals Specification and Application
Table 66. Jazz Pharmaceuticals Oligonucleotide API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 67. Jazz Pharmaceuticals Main Business and Markets Served
Table 68. Jazz Pharmaceuticals Recent Developments/Updates
Table 69. Sarepta Therapeutics Oligonucleotide API Corporation Information
Table 70. Sarepta Therapeutics Specification and Application
Table 71. Sarepta Therapeutics Oligonucleotide API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 72. Sarepta Therapeutics Main Business and Markets Served
Table 73. Sarepta Therapeutics Recent Developments/Updates
Table 74. Biogen Oligonucleotide API Corporation Information
Table 75. Biogen Specification and Application
Table 76. Biogen Oligonucleotide API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 77. Biogen Main Business and Markets Served
Table 78. Biogen Recent Developments/Updates
Table 79. Dynavax Technologies Oligonucleotide API Corporation Information
Table 80. Dynavax Technologies Specification and Application
Table 81. Dynavax Technologies Oligonucleotide API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 82. Dynavax Technologies Main Business and Markets Served
Table 83. Dynavax Technologies Recent Developments/Updates
Table 84. Akcea Therapeutics Oligonucleotide API Corporation Information
Table 85. Akcea Therapeutics Specification and Application
Table 86. Akcea Therapeutics Oligonucleotide API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 87. Akcea Therapeutics Main Business and Markets Served
Table 88. Akcea Therapeutics Recent Developments/Updates
Table 89. Alnylam Pharmaceuticals Oligonucleotide API Corporation Information
Table 90. Alnylam Pharmaceuticals Specification and Application
Table 91. Alnylam Pharmaceuticals Oligonucleotide API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 92. Alnylam Pharmaceuticals Main Business and Markets Served
Table 93. Alnylam Pharmaceuticals Recent Developments/Updates
Table 94. Nitto Denko (Avecia) Oligonucleotide API Corporation Information
Table 95. Nitto Denko (Avecia) Specification and Application
Table 96. Nitto Denko (Avecia) Oligonucleotide API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 97. Nitto Denko (Avecia) Main Business and Markets Served
Table 98. Nitto Denko (Avecia) Recent Developments/Updates
Table 99. Ajinomoto (GeneDesign) Oligonucleotide API Corporation Information
Table 100. Ajinomoto (GeneDesign) Specification and Application
Table 101. Ajinomoto (GeneDesign) Oligonucleotide API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 102. Ajinomoto (GeneDesign) Main Business and Markets Served
Table 103. Ajinomoto (GeneDesign) Recent Developments/Updates
Table 104. RiboBio Oligonucleotide API Corporation Information
Table 105. RiboBio Specification and Application
Table 106. RiboBio Oligonucleotide API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 107. RiboBio Main Business and Markets Served
Table 108. RiboBio Recent Developments/Updates
Table 109. Key Raw Materials Lists
Table 110. Raw Materials Key Suppliers Lists
Table 111. Oligonucleotide API Distributors List
Table 112. Oligonucleotide API Customers List
Table 113. Oligonucleotide API Market Trends
Table 114. Oligonucleotide API Market Drivers
Table 115. Oligonucleotide API Market Challenges
Table 116. Oligonucleotide API Market Restraints
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Oligonucleotide API
Figure 2. Global Oligonucleotide API Market Value by Type, (US$ Million) & (2023 VS 2030)
Figure 3. Global Oligonucleotide API Market Share by Type: 2023 VS 2030
Figure 4. Antisense Oligonucleotides API Product Picture
Figure 5. Small Interfering RNA (siRNA) API Product Picture
Figure 6. MiRNA API Product Picture
Figure 7. CpG Oligonucleotides API Product Picture
Figure 8. Others Product Picture
Figure 9. Global Oligonucleotide API Market Value by Application, (US$ Million) & (2023 VS 2030)
Figure 10. Global Oligonucleotide API Market Share by Application: 2023 VS 2030
Figure 11. Contract Manufacturing Organizations (CMOs)
Figure 12. Pharmaceutical Companies
Figure 13. Global Oligonucleotide API Production Value (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Oligonucleotide API Production Value (US$ Million) & (2019-2030)
Figure 15. Global Oligonucleotide API Production Capacity (Ton) & (2019-2030)
Figure 16. Global Oligonucleotide API Production (Ton) & (2019-2030)
Figure 17. Global Oligonucleotide API Average Price (US$/Ton) & (2019-2030)
Figure 18. Oligonucleotide API Report Years Considered
Figure 19. Oligonucleotide API Production Share by Manufacturers in 2023
Figure 20. Oligonucleotide API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 21. The Global 5 and 10 Largest Players: Market Share by Oligonucleotide API Revenue in 2023
Figure 22. Global Oligonucleotide API Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 23. Global Oligonucleotide API Production Value Market Share by Region: 2019 VS 2023 VS 2030
Figure 24. Global Oligonucleotide API Production Comparison by Region: 2019 VS 2023 VS 2030 (Ton)
Figure 25. Global Oligonucleotide API Production Market Share by Region: 2019 VS 2023 VS 2030
Figure 26. North America Oligonucleotide API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 27. Europe Oligonucleotide API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 28. China Oligonucleotide API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 29. Japan Oligonucleotide API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 30. Global Oligonucleotide API Consumption by Region: 2019 VS 2023 VS 2030 (Ton)
Figure 31. Global Oligonucleotide API Consumption Market Share by Region: 2019 VS 2023 VS 2030
Figure 32. North America Oligonucleotide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 33. North America Oligonucleotide API Consumption Market Share by Country (2019-2030)
Figure 34. Canada Oligonucleotide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 35. U.S. Oligonucleotide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 36. Europe Oligonucleotide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 37. Europe Oligonucleotide API Consumption Market Share by Country (2019-2030)
Figure 38. Germany Oligonucleotide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 39. France Oligonucleotide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 40. U.K. Oligonucleotide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 41. Italy Oligonucleotide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 42. Russia Oligonucleotide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 43. Asia Pacific Oligonucleotide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 44. Asia Pacific Oligonucleotide API Consumption Market Share by Regions (2019-2030)
Figure 45. China Oligonucleotide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 46. Japan Oligonucleotide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 47. South Korea Oligonucleotide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 48. China Taiwan Oligonucleotide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 49. Southeast Asia Oligonucleotide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 50. India Oligonucleotide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 51. Latin America, Middle East & Africa Oligonucleotide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 52. Latin America, Middle East & Africa Oligonucleotide API Consumption Market Share by Country (2019-2030)
Figure 53. Mexico Oligonucleotide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 54. Brazil Oligonucleotide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 55. Turkey Oligonucleotide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 56. GCC Countries Oligonucleotide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 57. Global Production Market Share of Oligonucleotide API by Type (2019-2030)
Figure 58. Global Production Value Market Share of Oligonucleotide API by Type (2019-2030)
Figure 59. Global Oligonucleotide API Price (US$/Ton) by Type (2019-2030)
Figure 60. Global Production Market Share of Oligonucleotide API by Application (2019-2030)
Figure 61. Global Production Value Market Share of Oligonucleotide API by Application (2019-2030)
Figure 62. Global Oligonucleotide API Price (US$/Ton) by Application (2019-2030)
Figure 63. Oligonucleotide API Value Chain
Figure 64. Oligonucleotide API Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
